| # | Drug | Count |
|---|---|---|
| 0 | DIAZEPAM | 8 |
| 1 | DIAZEPAM ORAL | 8 |
| 2 | DIAZEPAM ORAL SOLUTION (CONCENTRATE) | 8 |
| 3 | MOXIFLOXACIN | 6 |
| 4 | MOXIFLOXACIN HYDROCHLORIDE | 6 |
| 5 | METOCLOPRAMIDE | 4 |
| 6 | METOCLOPRAMIDE HYDROCHLORIDE | 4 |
| 7 | AMLODIPINE | 2 |
| 8 | ASPIRIN | 2 |
| 9 | ASPIRIN 325 MG | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | OLANZAPINE AND SAMIDORPHAN L-MALATE | 1 | 0.0006 |
| 1 | OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE | 1 | 0.0005 |
| 2 | MOXIFLOXACIN HYDROCHLORIDE | 6 | 0.0003 |
| 3 | CYPROHEPTADINE HYDROCHLORIDE | 1 | 0.0002 |
| 4 | DIAZEPAM ORAL | 8 | 0.0001 |
| 5 | DIAZEPAM | 8 | 0.0001 |
| 6 | METOCLOPRAMIDE HYDROCHLORIDE | 4 | 0.0001 |
| 7 | SOFOSBUVIR | 1 | 0.0001 |
| 8 | DONEPEZIL HYDROCHLORIDE | 1 | 0.0000 |
| 9 | CLONIDINE | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 1 | Central alpha-2 Adrenergic Agonist [EPC] | 1 | 0.0000 |
| 2 | Benzodiazepine [EPC] | 8 | 0.0000 |
| 3 | Central Nervous System Stimulant [EPC] | 1 | 0.0000 |
| 4 | Serotonin-3 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 5 | Dihydropyridine Calcium Channel Blocker [EPC] | 2 | 0.0000 |
| 6 | RANK Ligand Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Thiazide Diuretic [EPC] | 1 | 0.0000 |
| 8 | Atypical Antipsychotic [EPC] | 2 | 0.0000 |
| 9 | Platinum-based Drug [EPC] | 1 | 0.0000 |